Hurdle has achieved DCB0129 certification for Clinical Risk Management: its Application in the Manufacture of Health IT Systems

DCB0129 is published under section 250 of the Health and Social Care Act 2012 in the United Kingdom and will act as a significant milestone for the organisation as we continue to develop our digital health platforms.

Within Hurdle, our commitment to the management of risk for our digital health platforms is part of the company’s ongoing objectives. Monitoring and Vigilance of clinical risk allows a dynamic approach to mitigation and gives additional assurance to our partners and clients. Coupled with our certification to ISO27001:2022, DCB0129 provides a set of additional requirements, suitably structured to promote and ensure this effective application of risk management specific to our product. Where we, as a leading diagnostics service provider can act in a risk based approach towards the continued development of our digital health platforms for use within the home and healthcare environments in which we operate.

Being DCB0129 certified includes our full implementation of the standard and subsequent guidance documents. And as we move into 2025, this current certification will be further supported by the related standard for the application of clinical risk management in the deployment and use of Health IT Systems, entitled DCB0160. This will allow our customer complete confidence in not only the development of a world class digital health platform, but also the methods in which the platform will be deployed. That being both internally and also available at preference of our partners.